"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"
About Vaccines Summit-2021
Early Bird Deadline: October 23, 2020
Get your pass now until price go up & save 40%
Vaccines Summit-2021 invites the participants across the globe to attend its annual flagship conference on Vaccines Research and Development which is going to take place during September 20-22, 2021 in Washington DC.
Organized around the theme “next-generation vaccines treatment and diagnostics that save lives”, Vaccines Summit-2021 is comprised of various sessions designed to offer comprehensive symposiums that address current issues in the field of vaccine research and provides fantastic opportunity to network with your peers from academia and industry.
Vaccines Summit-2021 delivers unlimited opportunities for making business deals, product enhancements, cutting edge solutions for improving and elevating the company’s business and partnership. The conference provides a unique platform for all the leading industry professionals, institutional investors, capitalists, corporate investors and business development executives to have private One-to-One meetings with elite business representatives which increases the chances of marketing in this networking world.
Learn more about our event and how we can assist you with your research work & pipeline.
Adrian V. S. Hill, M.D., Ph.D.
Director, The Jenner Institute, Nuffield Department of Medicine, University of Oxford
Tal Zaks, M.D., Ph.D
Chief Medical Officer,
Jay A. Berzofsky, M.D., Ph.D.
Chief, Vaccine Branch,
Center for Cancer Research,
National Cancer Institute
David Weiner, M.D., Ph.D.
Executive Vice President, Director, Vaccine & Immunotherapy Center,
The Wistar Institute
Stephen L. Hoffman, M.D.
Chief Executive and Scientific Officer
Shan Lu, M.D., Ph.D.
Professor, Department of Medicine, University of Massachusetts Medical School, President Emeritus and Fellow, International Society for Vaccines
Dan Barouch, M.D., Ph.D.
Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
Lenny Moise, M.D., Ph.D.
Director of Vaccine Research, EpiVax, Inc.
Samir N. Khleif, M.D.
Director, Jeannie and Tony Loop Immuno-Oncology Research Laboratory, Lombardi Comprehensive Cancer Center
Nathalie Garçon, PharmD, Ph.D.
Chief Executive and Scientific Officer, CEO/CSO, IRT BIOASTER
Daniel F. Hoft, M.D., Ph.D.
Director, Division of Infectious Diseases, Allergy & Immunology, Department of Internal Medicine, Saint Louis University Medical Center
Nancy Sullivan, Ph.D.
Senior Investigator, Chief, Biodefense Research Section, VRC/NIAID/NIH
Thomas Breuer, M.D., M.Sc.
Senior Vice President & Chief Medical Officer, GSK Vaccines
Genoveffa Franchini, M.D.
Center for Cancer Research, National Cancer Institute (NCI), AMRVS, Vaccine Branch, National Institutes of Health
Barbara K. Felber, M.D.
Senior Investigator, Vaccine Branch, NCI/CCR
Stefan H.E. Kaufmann, Ph.D.
Director Emeritus, Max Planck Institute for Infection Biology
Alexander Bukreyev Ph.D.
Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch
Barney Graham, M.D., Ph.D.
Deputy Director, Vaccine Research Center, Chief, Viral Pathogenesis Laboratory and Translational Science Core